Treg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo
Roots Analysis has announced the addition of “Regulatory T-Cell (Tregs) Therapies Market, 2021 – 2035” report to its list of offerings.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
- A detailed assessment of the current market landscape of drug developers engaged in the development of regulatory T-cell therapies.
- A detailed analysis of more than 180+ completed, ongoing and planned clinical studies of regulatory T-cell therapies.
- Detailed profiles of developers of regulatory T-cell therapies (shortlisted on the basis of the number of pipeline products).
- An analysis of the partnerships that have been established in this domain, in the recent past.
- A detailed analysis of various investments undertaken by companies in this domain.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Type of Product
- Tregs
- Interleukins
- Small molecules
- Target Indication
- Crohn’s Disease
- Bipolar Disorder
- Allergic Rhinoconjunctivitis
- COVID 19
- Diabetes Mellitus
- Systemic Lupus Erythematosus
- Alzheimer’s Disease
- Graft Vs Host Disease
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
Key companies covered in the https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html
- Abata Therapeutics
- Cellenkos
- Coya Therapeutics
- ILTOO Pharma
- NEKTAR
- Roche
- Sonoma Biotherapeutics
- TeraImmune
- TRACT Therapeutics
For more information please click on the following link:
https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html or email [email protected]
Other Recent Offerings
- CD47 Targeting Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
- Antibody Drug Conjugates Market (6th Edition): Industry Trends and Global Forecasts, 2021-2030
- Novel T-Cell Immunotherapies Market: Industry Trends and Global Forecasts, 2021-2030
- TIL-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
- Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
- CRISPR Based Therapeutics Market: Focus on Cartridges, Syringes and Vials
- (2nd Edition), 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
